Floatz logo

Trientine

Wilson Disease

ExcelsiorSmall moleculePhase 3Dormant
BB
71/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
62/ 100
Competitive Position
89/ 100

Competitive context

12 Active assets in the Wilson Disease cohort.

Asset / SponsorPhaseRating
ZINC ACETATE
Nobelpharma
Phase 4BBB
Teta 4Hcl
Orphalan
Phase 3BBB
ZINC D-GLUCONATE (1:2)
Jun Li
Phase 4BBB
Penicillamine
Orphalan
Phase 3BB
Teta 4Hcl
Orphalan
Phase 3BB

View all 21 →

Same molecule, other indications

Trientine is also rated in:

malignant epithelial tumor of ovaryDormant
CCC
Indicative ·
52 / 100
View asset →
peritoneal carcinomaDormant
CCC
Indicative ·
52 / 100
View asset →
fallopian tube cancerDormant
CC
Indicative ·
44 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →